Form 8-K - Current report:
SEC Accession No. 0001615219-20-000102
Filing Date
2020-10-06
Accepted
2020-10-06 16:59:54
Documents
1
Period of Report
2020-10-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K slrxform8-k10062020.htm 8-K 23224
  Complete submission text file 0001615219-20-000102.txt   24461
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 201227344
SIC: 2834 Pharmaceutical Preparations